Transmembrane protein expressed in prostate and other cancers

Details for Australian Patent Application No. 2005202143 (hide)

Owner Agensys, Inc.

Inventors Afar, Daniel E.; Raitano, Arthur B.; Saffran, Douglas C; Hubert, Rene S.; Leong, Kahan

Agent FB Rice

Pub. Number AU-B-2005202143

Parent 780061

Filing date 18 May 2005

Wipo publication date 9 June 2005

Acceptance publication date 13 September 2007

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

2 June 2005 Complete Application Filed

9 June 2005 Application Open to Public Inspection

  Published as AU-B-2005202143

13 September 2007 Application Accepted

  Published as AU-B-2005202143

17 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005202144-Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

2005202142-Power steering assist